LEADER 01524oam  2200421   450 
001 9910707486203321
005 20221205105800.0
035   $a(CKB)5470000002464663
035   $a(OCoLC)956501710
035   $a(OCoLC)995470000002464663
035   $a(EXLCZ)995470000002464663
100   $a20160811d2007      ua             0
101 0 $aeng
135   $aurmn|||||||||
181   $2rdacontent
182   $2rdamedia
183   $2rdacarrier
200 14$aThe Food and Drug Administration's oversight of clinical trials
210  1$a[Washington, D.C.] :$cDepartment of Health and Human Services, Office of Inspector General,$d2007.
215   $a1 online resource (iv, 34 pages) $cillustrations
300   $aTitle from title screen (viewed Aug 9, 2016).
300   $a"September 2007."
300   $a"OEI-01-06-00160."
320   $aIncludes bibliographical references.
517 1 $aFood and Drug Administration's oversight of clinical trials
606   $aClinical trials$xGovernment policy$zUnited States
606   $aBiologicals$xTesting$xGovernment policy$zUnited States
606   $aDrugs$xTesting$xGovernment policy$zUnited States
615  0$aClinical trials$xGovernment policy
615  0$aBiologicals$xTesting$xGovernment policy
615  0$aDrugs$xTesting$xGovernment policy
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910707486203321
996   $aThe Food and Drug Administration's oversight of clinical trials$93461870
997   $aUNINA